Physician profile
Sun Cho
NPI 1689200677
$7,115.22
in general payments reported to CMS, 2019-2025
31 companies · $20.36 in 2025
The $20.36 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,470 · 2022: $2,627 · 2023: $731 · 2024: $267 · 2025: $20.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,204.98 | 2021-2024 | Ozempic, Rybelsus |
| Amgen INC. | $731.54 | 2021-2023 | Evenity, Prolia |
| Abbvie INC. | $555.14 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $539.99 | 2021-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $463.99 | 2021-2023 | |
| Lilly USA, LLC | $418.58 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $400.08 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $368.24 | 2021-2023 | |
| Amarin Pharma, INC. | $318.90 | 2021-2023 | |
| Eisai INC. | $264.54 | 2021-2022 | |
| Gilead Sciences, INC. | $238.44 | 2021-2024 | Vemlidy |
| Radius Health, INC. | $225.54 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $217.49 | 2021-2023 | Jardiance |
| Astellas Pharma US INC | $200.98 | 2021-2023 | Myrbetriq |
| Nestle Healthcare Nutrition INC. | $177.16 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $175.44 | 2021-2024 | |
| Scilex Pharmaceuticals INC. | $162.96 | 2021-2023 | Ztlido |
| Merck Sharp & Dohme LLC | $113.27 | 2021 | |
| Vivus LLC | $77.39 | 2021-2022 | |
| Ibsa Pharma INC. | $44.09 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $36.23 | 2022 | |
| Exact Sciences Corporation | $29.65 | 2023-2024 | Cologuard Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $18.93 | 2022 | |
| Sanofi Pasteur INC. | $18.10 | 2023 | |
| Corium, LLC | $17.93 | 2023 | Adlarity |
| Takeda Pharmaceuticals U.S.A., INC. | $17.90 | 2021 | |
| Vbi Vaccine (Delaware) INC. | $17.49 | 2023 | Prehevbrio |
| Genentech USA, INC. | $16.99 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.53 | 2021 | |
| Ironwood Pharmaceuticals, INC | $14.38 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sun Cho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.